Total Payments
$6,357
2024 Payments
$1,047
Companies
45
Transactions
293
Medicare Patients
2,614
Medicare Billing
$248,107
Payment Breakdown by Category
Food & Beverage$6,357 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,357 | 293 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $688.32 | 51 | $0 (2024) |
| Lilly USA, LLC | $584.20 | 31 | $0 (2024) |
| PFIZER INC. | $520.69 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $450.83 | 25 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $399.83 | 5 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $311.87 | 17 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $309.47 | 17 | $0 (2024) |
| Amgen Inc. | $280.70 | 15 | $0 (2024) |
| Cumberland Pharmaceuticals, Inc. | $273.74 | 13 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $244.04 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,047 | 46 | Lilly USA, LLC ($168.50) |
| 2023 | $1,365 | 77 | Lilly USA, LLC ($223.43) |
| 2022 | $1,031 | 60 | Novo Nordisk Inc ($219.06) |
| 2021 | $585.43 | 35 | Novo Nordisk Inc ($121.80) |
| 2020 | $433.65 | 26 | Novo Nordisk Inc ($88.20) |
| 2019 | $210.43 | 6 | PFIZER INC. ($119.32) |
| 2018 | $516.60 | 20 | Novartis Pharmaceuticals Corporation ($188.39) |
| 2017 | $1,167 | 23 | Boehringer Ingelheim Pharmaceuticals, Inc. ($246.44) |
All Payment Transactions
293 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Inflammation | ||||||
| 12/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/05/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/08/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Neuroscience | ||||||
| 11/02/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/10/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Obesity | ||||||
| 09/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: Obesity | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $31.44 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: Oncology | ||||||
| 08/22/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.03 | General |
| 08/16/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 08/15/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CRITICAL CARE | ||||||
| 08/09/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 08/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 07/12/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/09/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Diabetes | ||||||
| 07/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: Diabetes | ||||||
| 06/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: Respiratory | ||||||
| 06/07/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Insomnia | ||||||
| 05/15/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 668 | 948 | $141,691 | $63,113 |
| 2022 | 17 | 694 | 1,008 | $135,424 | $68,779 |
| 2021 | 14 | 713 | 900 | $128,896 | $66,568 |
| 2020 | 12 | 539 | 723 | $105,578 | $49,646 |
Total Patients
2,614
Total Services
3,579
Medicare Billing
$248,107
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 173 | $32,005 | $17,907 | 55.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 65 | 65 | $13,103 | $9,684 | 73.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 70 | 74 | $30,044 | $7,989 | 26.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 87 | $13,050 | $6,241 | 47.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 53 | 71 | $19,170 | $5,058 | 26.4% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 15 | 25 | $7,653 | $4,134 | 54.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 43 | 43 | $4,606 | $3,254 | 70.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 32 | 40 | $2,800 | $1,833 | 65.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 46 | 46 | $2,300 | $1,655 | 72.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 126 | $4,410 | $1,403 | 31.8% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 34 | 36 | $3,420 | $1,092 | 31.9% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 27 | 35 | $2,450 | $1,040 | 42.4% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 17 | 18 | $1,350 | $819.54 | 60.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 60 | 79 | $1,580 | $663.60 | 42.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 28 | 30 | $3,750 | $341.40 | 9.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 110 | 211 | $39,035 | $22,949 | 58.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 52 | 52 | $10,483 | $7,981 | 76.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 79 | $11,850 | $6,800 | 57.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 46 | 50 | $17,550 | $4,817 | 27.4% |
| 99350 | Established patient home visit, typically 1 hour | Office | 2022 | 13 | 28 | $8,572 | $4,670 | 54.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 39 | 80 | $5,600 | $4,267 | 76.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 40 | 50 | $12,250 | $3,312 | 27.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 44 | 44 | $3,960 | $3,091 | 78.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 13 | 13 | $3,840 | $2,588 | 67.4% |
| 0094A | Adm sarscov2 50 mcg/.5 mlbst | Office | 2022 | 45 | 45 | $3,075 | $2,037 | 66.3% |
About Igor Elman
Igor Elman is a Hospitalist healthcare provider based in New City, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2015. The National Provider Identifier (NPI) number assigned to this provider is 1285024026.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Igor Elman has received a total of $6,357 in payments from pharmaceutical and medical device companies, with $1,047 received in 2024. These payments were reported across 293 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($6,357).
As a Medicare-enrolled provider, Elman has provided services to 2,614 Medicare beneficiaries, totaling 3,579 services with total Medicare billing of $248,107. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Other Specialties Internal Medicine, Hospitalist
- Location New City, NY
- Active Since 02/02/2015
- Last Updated 01/05/2026
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1285024026
Products in Payments
- ELIQUIS (Drug) $500.76
- JARDIANCE (Drug) $490.34
- DUPIXENT (Biological) $309.47
- ENTRESTO (Drug) $245.05
- SOLIRIS (Drug) $244.04
- Kerendia (Drug) $235.81
- Ozempic (Drug) $235.56
- NORTHERA (Drug) $209.84
- EMGALITY (Drug) $189.31
- Caldolor (Drug) $173.66
- Cologuard Collection Kit (Device) $169.06
- MOUNJARO (Drug) $160.93
- QUVIVIQ (Drug) $157.76
- Otezla (Drug) $157.32
- XOLAIR (Drug) $141.92
- CONTRAVE (Drug) $136.69
- TERLIVAZ (Drug) $125.00
- NURTEC ODT (Drug) $107.47
- Rybelsus (Drug) $102.41
- Vaprisol (Drug) $94.14
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.